Christopher Patusky insider trades: UNITED THERAPEUTICS (UTHR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
68 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | UTHR | ↓ Sell | 1,000 | $578.88 | $579K | Direct | Apr 17, 2026 (0d) |
| Dec 15, 2025 | UTHR | ↓ Sell | 1,000 | $495.95 | $496K | Direct | Dec 16, 2025 (1d) |
| Mar 19, 2025 | UTHR | ↓ Sell | 5,000 | $310.72 | $1.6M | Direct | Mar 20, 2025 (1d) |
| Jan 10, 2025 | UTHR | ↓ Sell | 5,000 | $361.61 | $1.8M | Direct | Jan 13, 2025 (3d) |
| Sep 4, 2024 | UTHR | ↓ Sell | 5,000 | $354.33 | $1.8M | Direct | Sep 5, 2024 (1d) |
| Jun 17, 2024 | UTHR | ↓ Sell | 2,000 | $295.50 | $591K | Direct | Jun 18, 2024 (1d) |
| May 14, 2024 | UTHR | ↓ Sell | 1,310 | $264.35 | $346K | Direct | May 15, 2024 (1d) |
| Feb 23, 2024 | UTHR | ↓ Sell | 1,680 | $224.00 | $376K | Direct | Feb 26, 2024 (3d) |
| Nov 17, 2022 | UTHR | ↓ Sell | 100 | $262.61 | $26K | By Trust | Nov 18, 2022 (1d) |
| Nov 8, 2021 | UTHR | ↓ Sell | 2,300 | $200.16 | $460K | Direct | Nov 8, 2021 (0d) |
| May 10, 2021 | UTHR | ↓ Sell | 100 | $190.52 | $19K | By Family Trust | May 10, 2021 (0d) |
| Jun 10, 2019 | UTHR | ↑ Buy | 21 | $115.35 | $2K | Direct | May 3, 2023 (1423d) |
| Mar 7, 2019 | UTHR | ↓ Sell | 3,370 | $110.75 | $373K | Direct | Mar 8, 2019 (1d) |
| Dec 28, 2018 | UTHR | ↓ Sell | 17 | $111.37 | $2K | Direct | May 3, 2023 (1587d) |
| Jan 12, 2017 | UTHR | ↓ Sell | 5,000 | $141.99 | $710K | Direct | Jan 12, 2017 (0d) |
| Nov 10, 2016 | UTHR | ↓ Sell | 5,000 | $131.42 | $657K | Direct | Nov 14, 2016 (4d) |
| Sep 1, 2016 | UTHR | ↓ Sell | 5,000 | $122.73 | $614K | Direct | Sep 2, 2016 (1d) |
| Mar 5, 2015 | UTHR | ↓ Sell | 5,000 | $161.36 | $807K | Direct | Mar 6, 2015 (1d) |
| Feb 27, 2015 | UTHR | ↓ Sell | 7,500 | $155.05 | $1.2M | Direct | Feb 27, 2015 (0d) |
| Jan 8, 2015 | UTHR | ↓ Sell | 5,000 | $128.13 | $641K | Direct | Jan 12, 2015 (4d) |
| Dec 4, 2014 | UTHR | ↓ Sell | 5,000 | $129.05 | $645K | Direct | Dec 4, 2014 (0d) |
| Nov 7, 2014 | UTHR | ↓ Sell | 5,000 | $124.49 | $622K | Direct | Nov 7, 2014 (0d) |
| Aug 7, 2014 | UTHR | ↓ Sell | 5,000 | $88.23 | $441K | Direct | Aug 11, 2014 (4d) |
| May 8, 2014 | UTHR | ↓ Sell | 5,000 | $107.17 | $536K | Direct | May 9, 2014 (1d) |
| Mar 6, 2014 | UTHR | ↓ Sell | 5,000 | $101.39 | $507K | Direct | Mar 6, 2014 (0d) |
| Jan 9, 2014 | UTHR | ↓ Sell | 5,000 | $110.00 | $550K | Direct | Jan 9, 2014 (0d) |
| Nov 14, 2013 | UTHR | ↓ Sell | 5,500 | $91.65 | $504K | Direct | Nov 14, 2013 (0d) |
| Nov 7, 2013 | UTHR | ↓ Sell | 3,500 | $90.51 | $317K | Direct | Nov 7, 2013 (0d) |
| Aug 1, 2013 | UTHR | ↓ Sell | 3,500 | $75.49 | $264K | Direct | Aug 1, 2013 (0d) |
| May 2, 2013 | UTHR | ↓ Sell | 3,500 | $66.75 | $234K | Direct | May 2, 2013 (0d) |
| Mar 1, 2013 | UTHR | ↓ Sell | 6,000 | $60.07 | $360K | Direct | Mar 1, 2013 (0d) |
| Jan 3, 2013 | UTHR | ↓ Sell | 8,000 | $53.02 | $424K | Direct | Jan 3, 2013 (0d) |
| Oct 3, 2012 | UTHR | ↓ Sell | 2,000 | $58.38 | $117K | Direct | Oct 3, 2012 (0d) |
| Sep 5, 2012 | UTHR | ↓ Sell10b5-1 | 2,000 | $55.47 | $111K | Direct | Sep 6, 2012 (1d) |
| Aug 1, 2012 | UTHR | ↓ Sell | 2,000 | $54.69 | $109K | Direct | Aug 2, 2012 (1d) |
| Apr 4, 2012 | UTHR | ↓ Sell | 2,500 | $45.55 | $114K | Direct | Apr 6, 2012 (2d) |
| Mar 7, 2012 | UTHR | ↓ Sell10b5-1 | 2,500 | $45.13 | $113K | Direct | Mar 7, 2012 (0d) |
| Feb 1, 2012 | UTHR | ↓ Sell | 2,500 | $49.24 | $123K | Direct | Feb 2, 2012 (1d) |
| Jan 4, 2012 | UTHR | ↓ Sell10b5-1 | 7,500 | $47.93 | $359K | Direct | Jan 4, 2012 (0d) |
| Jun 8, 2011 | UTHR | ↓ Sell10b5-1 | 2,500 | $59.22 | $148K | Direct | Jun 10, 2011 (2d) |
| May 11, 2011 | UTHR | ↓ Sell10b5-1 | 2,500 | $67.19 | $168K | Direct | May 12, 2011 (1d) |
| Apr 13, 2011 | UTHR | ↓ Sell10b5-1 | 2,500 | $66.18 | $165K | Direct | Apr 14, 2011 (1d) |
| Mar 9, 2011 | UTHR | ↓ Sell10b5-1 | 2,500 | $68.75 | $172K | Direct | Mar 9, 2011 (0d) |
| Mar 3, 2011 | UTHR | ↓ Sell10b5-1 | 9,000 | $68.63 | $618K | Direct | Mar 4, 2011 (1d) |
| Feb 9, 2011 | UTHR | ↓ Sell10b5-1 | 2,500 | $66.61 | $167K | Direct | Feb 9, 2011 (0d) |
| Jan 12, 2011 | UTHR | ↓ Sell10b5-1 | 1,000 | $67.14 | $67K | Direct | Jan 12, 2011 (0d) |
| Dec 2, 2010 | UTHR | ↓ Sell10b5-1 | 2,000 | $62.64 | $125K | Direct | Dec 2, 2010 (0d) |
| Nov 29, 2010 | UTHR | ↓ Sell | 1,700 | $62.00 | $105K | By Family Trust | Dec 2, 2010 (3d) |
| Nov 4, 2010 | UTHR | ↓ Sell10b5-1 | 6,000 | $60.31 | $362K | Direct | Nov 4, 2010 (0d) |
| Oct 7, 2010 | UTHR | ↓ Sell10b5-1 | 3,600 | $55.23 | $199K | Direct | Oct 8, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other UTHR insiders
Open-market trades in the last 12 months
About Christopher Patusky's insider trades
Christopher Patusky is an insider at UNITED THERAPEUTICS (UTHR). Since May 6, 2005, Christopher has reported 1 open-market purchase worth $2K and 67 sales worth $25.9M on SEC Form 4. In the last 12 months: 2 sales ($1.1M).
23 sales (17% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (95 filings), shares returned to the company (28 filings), grants and awards (19 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.